PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.02
+0.00%Institutional positioning
13F filings over the trailing two quarters
New 8Increased 3Reduced 0Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Yorkville Advisors Global, LP | New Position | 81,103 | Aug 6, 2026 |
| JANE STREET GROUP, LLC | New Position | 80,387 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 28,575 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | New Position | 13,220 | May 15, 2026 |
| UBS Group AG | Increased | 10,415 | Aug 13, 2026 |
| MORGAN STANLEY | Increased | 2,783 | Aug 13, 2026 |
| MORGAN STANLEY | New Position | 1,611 | May 15, 2026 |
| UBS GROUP AG | New Position | 869 | May 5, 2026 |
| ROYAL BANK OF CANADA | New Position | 233 | Aug 14, 2026 |
| OSAIC HOLDINGS, INC. | Unchanged | 40 | Aug 14, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | New Position | 40 | May 15, 2026 |
| Rockefeller Capital Management L.P. | New Position | 1 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings